IMRX

Up next

Next earnings call

Dec 19, 2026 Est · unconfirmed · in 23 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed May 15, 2026

Equibles Rating blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Neutral Momentum Strong Sentiment Bullish Fundamentals Fair Quant / Vol Very High

Market backdrop VIX 15 · calm Equity put/call 0.55

Technical

price trend

Neutral

50 / 200-day cross No cross

Price vs 200-day avg −9%

below

Price vs 50-day avg +5%

above

RSI (14) 55

neutral

MACD trend Positive

52-week position 31%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Strong

1-month return +30%

trailing

6-month return +10%

trailing

YTD return −22%

this year

Relative strength +1%

vs S&P · 6-mo

Sentiment

smart money

Bullish

Trend (MA cross) No cross

50d $5 › 200d $6 — 200d above 50d

Institutional flow Accumulating

4 of 95 funds reported for Jun 30 · net +12.3K sh shares · +1 new

Insider flow Accumulating

Net +$36.0K over 90 days · 0% sells

Short interest Rising

23.23% of float · ▲ +7.1% MoM · 7.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

95 holders — near 3-yr high, broad support

Squeeze score 79

high risk · 0–100

Fundamentals

Fair

Revenue growth −100%

Y/Y

EPS growth +38%

Y/Y

Free cash flow $-45.5M

Balance sheet $128.6M

net cash

Quant / Vol

risk profile

Very High

Volatility 104%

annualized · 1-yr

Max drawdown −58%

past year

ATR 6.6%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral

1 · 4 · 2

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

−9% Bearish

Price vs 50-day avg

+5% Bullish

RSI (14)

55 Neutral

MACD trend

Positive Bullish

52-week position

31% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bullish · 3 of 6

Trend (MA cross) No cross

50d $5 › 200d $6 — 200d above 50d

Institutional flow Accumulating

4 of 95 funds reported for Jun 30 · net +12.3K sh shares · +1 new

Insider flow Accumulating

Net +$36.0K over 90 days · 0% sells

Short interest Rising

23.23% of float · ▲ +7.1% MoM · 7.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

95 holders — near 3-yr high, broad support

Price context

position in its 52-week range

52-wk low $3 Now $5 · 31% 52-wk high $10

vs 200-day avg -9% vs 50-day avg +5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings

Metric	Latest	Period	YoY
Cash, cash equivalents and marketable securities	$198.6M	First Quarter 2026	—

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Biotechnology — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
IMRX Immuneering Corp this stock	$330.60M	-22.3%	-84.8%	—	23.2%
ONC BeOne Medicines Ltd.	$431.70B	-1.7%	+22179.2%	878.5	0.1%
VRTX Vertex Pharmaceuticals Inc / Ma	$123.19B	+7.1%	+46.2%	28.8	1.9%
REGN Regeneron Pharmaceuticals, Inc.	$69.67B	-13.8%	+20.8%	16.2	3.3%
ARGX Argenx SE	$54.85B	+4.4%	—	—	2.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

96

% held: 45.9%
Reported: 4 of 95
Top holder: FMR LLC

Held Float

View

Held by Funds

Fund positions

35

View

Short & Settlement

Short Interest Rising

Shares short

15.0M

Days to cover: 7.6d
Change: +1.0M sh

View

Short Volume

Short vol %

60%

As of: Jul 10, 2026

Short Total

View

Fails to Deliver

FTD shares

30.0K

Value: $123.6K
As of: Jun 12, 2026

View

Off-Exchange

Off-exchange %

57.6%

Week of: May 4, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net buying

Net (90d)

+$36.0K

Buyers / Sellers: 2 / 0

Buyers Sellers

View

Financials

Revenue (FY)

$0

Net income (FY): $-56.0M
EPS diluted: $-1.27

View

Filings

SEC Filings

Latest

8-K

Filed: Jun 15, 2026
This year: 9

View

Proposed Sales

Value

$136.1K

Shares: 14.0K
Filed: Sep 23, 2025

View

Exempt Offerings

Offering

$25.0M

Filed: Sep 9, 2025

View

Earnings & Events

Earnings Calls

Last call

Jun 1, 2026

View

	5D	20D	120D	MTD	YTD
IMRX	-1.5%	+30.4%	+10.1%	+2.4%	-22.3%
SPY	+1.4%	+4.1%	+9.1%	+1.1%	+10.7%
vs SPY	-2.9%	+26.3%	+1.1%	+1.3%	-33.1%

Price & Indicators

Technicals

Key metrics

Versus peers

At a glance

Performance